Effects of Skeletally Anchored Maxillary Expander Via Two Approaches of Microosteoperforations

NCT ID: NCT05433038

Last Updated: 2022-06-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-05-20

Study Completion Date

2024-11-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

study will be directed to evaluate two approaches of microosteoperforations during skeletally anchored maxillary expansion

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Dento-skeletal effects of skeletally anchored maxillary expander assisted with two approaches of microosteoperforations.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Posterior Crossbite

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

skeletal expander with microosteoperforation in mid palatine

group1.will include ten patients undergo skeletally anchored maxillary expander with microosteoperforation in mid palatine suture

Group Type ACTIVE_COMPARATOR

skeletally anchored maxillary expander

Intervention Type DEVICE

used from day one and activated two times per day for two weeks

skeletal expander with microosteoperforation in mid palatine and buccally

group2.will include ten patients undergo skeletally anchored maxillary expander with microosteoperforation in mid palatine suture and buccally

Group Type ACTIVE_COMPARATOR

skeletally anchored maxillary expander

Intervention Type DEVICE

used from day one and activated two times per day for two weeks

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

skeletally anchored maxillary expander

used from day one and activated two times per day for two weeks

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

mini implant assisted rapid palatine expander

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients should satisfy the following criteria:-

1. An age range from 18-22.
2. Transverse maxillary deficiency.
3. Crossbite (unilateral or bilateral)
4. No previous orthodontic treatment.
5. Good oral and general health.
6. No systemic disease/ medication that could interfere with OTM.

Exclusion Criteria

1. History of systemic and medical illness.
2. History of extraction of permanent teeth.
3. Previos orthodontic treatment.
4. Poor oral hygiene or periodontally compromised patient.
5. Patient with craniofacial anomaly or previous history of trauma,bruxism or parafunctions.
Minimum Eligible Age

18 Years

Maximum Eligible Age

22 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Al-Azhar University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Amgad Ragab Alawady kaoah

BDS(2006),faculty of dental medicine suze canal university

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Al-Azhar univesity

Cairo, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

798/1901

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.